|
Video: What is a Stock Split?
|
|
Juniper Pharmaceuticals is engaged in in the business of developing, licensing, manufacturing and selling to its marketing partners pharmaceutical products that utilize its drug delivery technologies to treat various medical conditions. Co.'s products include bioadhesive vaginal gel products for infertility, pregnancy support, amenorrhea, and other women's health conditions, and a bioadhesive buccal system for male hypogonadism. Co. has partnered or sold each of these products for commercialization in various regions of the world. All of the products Co. has developed utilize its Bioadhesive Delivery System, which consists principally of a polymer (polycarbophil) and an active ingredient. According to our CBRX split history records, CBRX has had 1 split. | |
|
CBRX (CBRX) has 1 split in our CBRX split history database. The split for CBRX took place on August 09, 2013. This was a 1 for 8 reverse split, meaning for each 8 shares of CBRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.
When a company such as CBRX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CBRX split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CBRX shares, starting with a $10,000 purchase of CBRX, presented on a split-history-adjusted basis factoring in the complete CBRX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/10/2015 |
|
Start price/share: |
$6.85 |
|
End price/share: |
$7.36 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
7.45% |
|
Annualized Gain: |
7.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,745.00 |
|
Years: |
0.96 |
|
|
|
Date |
Ratio |
08/09/2013 | 1 for 8 |
|
|